Clinical Trials Browser

Recurrence, Rhabdomyosarcoma, Sarcoma, Sarcoma, Ewing, Osteosarcoma

NCT06114225 2023-11-02

PROMIS

Phase 2 Recruiting

43 enrolled

Sarcoma

Osteosarcoma

NCT05116800 2021-12-07

Phase 2 Study of 9-ING-41 With Chemotherapy in Sarcoma

Phase 2 Withdrawn

Sarcoma

Bone Neoplasms, Hemangiosarcoma, Leiomyosarcoma, Liposarcoma, Rhabdomyosarcoma, Sarcoma, Osteosarcoma, Sarcoma, Synovial, Dermatofibrosarcoma, Histiocytoma, Malignant Fibrous

NCT02718482 2019-05-13

OsteoREC2015

Phase 2 Terminated

7 enrolled

Sarcoma

Osteosarcoma

NCT02429973 2015-04-29

GEIS-29

Phase 2 Completed

33 enrolled

Sarcoma

Osteosarcoma

NCT00073983 2012-03-12

Gemcitabine and Docetaxel in Treating Patients With Recurrent Osteosarcoma (Closed to Accrual as of 12/21/06) or Ewing's Sarcoma or Unresectable or Locally Recurrent Chondrosarcoma

Phase 2 Completed

54 enrolled 8 charts

Sarcoma

Chondrosarcoma, Sarcoma, Osteosarcoma, Neuroectodermal Tumors, Primitive, Peripheral

NCT00407433 2009-08-07

Clinical Studies of Gemcitabine-Oxaliplatin

Phase 2 Completed

156 enrolled

CNSSarcoma

Medulloblastoma, Neuroblastoma, Osteosarcoma, Central Nervous System Neoplasms

Clinical Trials

Nab-Paclitaxel and Gemcitabine for Recurrent/Refractory Sarcoma

PROMIS

Phase 2 Study of 9-ING-41 With Chemotherapy in Sarcoma

OsteoREC2015

GEIS-29

Gemcitabine and Docetaxel in Treating Patients With Recurrent Osteosarcoma (Closed to Accrual as of 12/21/06) or Ewing's Sarcoma or Unresectable or Locally Recurrent Chondrosarcoma

Clinical Studies of Gemcitabine-Oxaliplatin